General Hospital Psychiatry 2012-01-01

Acute neurogenic pulmonary edema following electroconvulsive therapy: a case report.

Tohru Takahashi, Kuni Kinoshita, Tomonori Fuke, Kazuhisa Urushihata, Tomoyuki Kawamata, Shin Yanagisawa, Tomoki Kaneko, Shinsuke Washizuka, Tokiji Hanihara, Naoji Amano

Index: Gen. Hosp. Psychiatry 34(6) , 703.e9-703.e11, (2012)

Full Text: HTML

Abstract

We report the case of a 47-year-old man with depression who developed acute dyspnea, hypoxemia, and mild hemoptysis after electroconvulsive therapy (ECT).Intravenous carbazochrome sodium sulfate hydrate as a hemostatic drug (100 mg/day) was prescribed for 2 days. On the day of ECT, oxygen inhalation (4 L/min) was continued, and SpO2 was maintained at 94-96%.Chest radiography showed improvement in alveolar infiltration. Chest CT 6 days after ECT also confirmed the disappearance of ground glass opacities in the lung fields.NPE is life threatening and should be recognized as an uncommon adverse event associated with ECT.Copyright © 2012 Elsevier Inc. All rights reserved.

Related Compounds

Related Articles:

[Host-guest molecule interaction mechanism of hemostatics with liposomes and red blood cells studied with fluorescence polarimetric method].

1998-05-01

[Yao Xue Xue Bao 33(5) , 362-8, (1998)]

Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study.

2001-01-01

[Curr. Med. Res. Opin. 17(4) , 256-61, (2001)]

Short-term delayed-release microcapsules spraycoated with acrylic terpolymers.

2006-01-13

[Int. J. Pharm. 307(2) , 300-7, (2006)]

Determination of carbazochrome by fluorescence quenching method.

2012-11-01

[Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 97 , 161-6, (2012)]

Carbazochrome sodium sulfonate (AC-17) reverses endothelial barrier dysfunction through inhibition of phosphatidylinositol hydrolysis in cultured porcine endothelial cells.

2003-09-01

[Naunyn Schmiedebergs Arch. Pharmacol. 368(3) , 175-80, (2003)]

More Articles...